Sodium Channel Blocker Tolerance as a Metric for Disease Modification in Dravet Syndrome
Annals of the Child Neurology Society · 2026-09 · 4 (3) · 175-176
DOI: 10.1002/cns3.70078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Child Neurology Society, online erschienen am 23.06.2026. Verfasst von Koichiro Yuji und 1 weiteren Autor:innen. Beteiligte Einrichtung: Project Division of International Healthcare Innovation Research, The Institute of Medical Science The University of Tokyo Tokyo Japan. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Project Division of International Healthcare Innovation Research, The Institute of Medical Science The University of Tokyo Tokyo Japan.
- Department of Research, Clinical Trial Center Kitasato Institute Hospital Tokyo Japan.
ORCID-Profile: Koichiro Yuji
Zitieren
APA
Yuji, K., & Yuji, W. (2026). Sodium Channel Blocker Tolerance as a Metric for Disease Modification in Dravet Syndrome. Annals of the Child Neurology Society, 4(3), 175-176. https://doi.org/10.1002/cns3.70078
Vancouver
Yuji K, Yuji W. Sodium Channel Blocker Tolerance as a Metric for Disease Modification in Dravet Syndrome. Annals of the Child Neurology Society. 2026;4(3):175-176. doi:10.1002/cns3.70078
BibTeX
@article{Yuji2026,
author = {Yuji, Koichiro and Yuji, Wakako},
title = {Sodium Channel Blocker Tolerance as a Metric for Disease Modification in Dravet Syndrome},
journal = {Annals of the Child Neurology Society},
year = {2026},
volume = {4},
number = {3},
pages = {175--176},
doi = {10.1002/cns3.70078}
}
EUVIMED